Cargando…

High Oxytocin Receptor Expression Linked to Increased Cell Migration and Reduced Survival in Patients with Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited treatment options and high mortality. The oxytocin receptor (OTR) is a class-A G protein-coupled receptor that has been linked to breast cancer, but its role in tumorigenesis and disease progression remains unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Huiping, Muttenthaler, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313263/ https://www.ncbi.nlm.nih.gov/pubmed/35884900 http://dx.doi.org/10.3390/biomedicines10071595

Ejemplares similares

The oxytocin receptor signalling system and breast cancer: a critical review
por: Liu, Huiping, et al.
Publicado: (2020)

Insights into the molecular evolution of oxytocin receptor ligand binding
por: Koehbach, Johannes, et al.
Publicado: (2013)

Photoswitchable Probes of Oxytocin and Vasopressin
por: Wirth, Ulrike, et al.
Publicado: (2023)

Approaches to Improve the Quantitation of Oxytocin in Human Serum by Mass Spectrometry
por: Hering, Anke, et al.
Publicado: (2022)

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023)

Pharmacological chaperones for the oxytocin receptor increase oxytocin responsiveness in myometrial cells
por: Malik, Manasi, et al.
Publicado: (2022)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas
por: Changavi, Arathi A, et al.
Publicado: (2015)

Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival
por: Oprea-Ilies, Gabriela, et al.
Publicado: (2012)

Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
por: Norton, Nadine, et al.
Publicado: (2020)

Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells
por: Bar, Isabelle, et al.
Publicado: (2018)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Comparison of the expression levels of lysine-specific demethylase 1 and survival outcomes between triple-negative and non-triple-negative breast cancer
por: Zhao, Kangrong, et al.
Publicado: (2021)

Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells
por: Fernandez-Gallardo, Miriam, et al.
Publicado: (2016)

ELOVL2-AS1 inhibits migration of triple negative breast cancer
por: Zhu, Mingda, et al.
Publicado: (2022)

Three-microRNA expression signature predicts survival in triple-negative breast cancer
por: Wu, Xinquan, et al.
Publicado: (2020)

Increased macroH2A1.1 Expression Correlates with Poor Survival of Triple-Negative Breast Cancer Patients
por: Lavigne, Anne-Claire, et al.
Publicado: (2014)

Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes
por: Ribeiro, Enilze, et al.
Publicado: (2013)

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
por: Torres-Ruiz, Sandra, et al.
Publicado: (2023)

The expression of Rab5 and its effect on invasion, migration and exosome secretion in triple negative breast cancer
por: Qiao, Lei, et al.
Publicado: (2023)

BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer
por: Wang, Xin, et al.
Publicado: (2020)

Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival
por: Mansouri, Hanane, et al.
Publicado: (2020)

The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival
por: Yu, Linghong, et al.
Publicado: (2022)

ODP433 An increased in AIPB expression in Triple Negative (ER-/PR-/Her2-) Breast Tumors reduces estradiol synthesis
por: Downs, William V, et al.
Publicado: (2022)

Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits
por: Baribeau, Danielle A., et al.
Publicado: (2015)

Oxytocin Reduces Intravesical Pressure in Anesthetized Female Rats: Action on Oxytocin Receptors of the Urinary Bladder
por: Cafarchio, Eduardo M., et al.
Publicado: (2020)

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells
por: Zajac, Olivier, et al.
Publicado: (2020)

Downregulation of fascin induces collective cell migration in triple‑negative breast cancer
por: Yamamoto, Yumiko, et al.
Publicado: (2023)

The organizational effects of oxytocin on the central expression of estrogen receptor α and oxytocin in adulthood
por: Kramer, Kristin M, et al.
Publicado: (2007)

Brain areas affected by intranasal oxytocin show higher oxytocin receptor expression
por: Habets, Philippe C., et al.
Publicado: (2021)

Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
por: Al-saraireh, Yousef M, et al.
Publicado: (2021)

Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4
por: Grottke, Astrid, et al.
Publicado: (2016)

Oxytocin and cancer: An emerging link
por: Lerman, Ben, et al.
Publicado: (2018)

Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
por: Lee, Reeree, et al.
Publicado: (2022)

Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria
por: Haruna, Muibat, et al.
Publicado: (2022)

RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer
por: Cuesta, Rafael, et al.
Publicado: (2016)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer
por: Prat, A, et al.
Publicado: (2014)

Impact of radiation therapy on survival in patients with triple-negative breast cancer
por: STEWARD, LAUREN T., et al.
Publicado: (2014)

A nomogram prediction for the survival of patients with triple negative breast cancer
por: Lin, Yuxiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d4rmhpnq7f0chetuo701k0f44f